Zogenix, Inc.
Overview
Zogenix, Inc. is a biopharmaceutical company dedicated to developing and commercializing therapies targeting rare diseases. It is a subsidiary of UCB, a global biopharmaceutical company specializing in neurology and immunology.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Zogenix, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Verified Supplier Partner
Is this Zogenix, Inc.? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Related companies
Alexza Pharmaceuticals, Inc.
United States
Genzyme Corporation
United States
Innovative Healthcare Solutions Inc.
United States
Regeneron Pharmaceuticals, Inc.
United States
Takeda Pharmaceuticals U.S.A., Inc.
United States
Boehringer Mannheim Pharmaceuticals Corp. (now part of Roche)
Switzerland
Fermion Pharmaceuticals Ltd.
Finland
Horizon Therapeutics Public Limited Company
Ireland
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.